542 related articles for article (PubMed ID: 18423777)
21. Behavioral and serotonergic consequences of decreasing or increasing hippocampus brain-derived neurotrophic factor protein levels in mice.
Deltheil T; Guiard BP; Cerdan J; David DJ; Tanaka KF; Repérant C; Guilloux JP; Coudoré F; Hen R; Gardier AM
Neuropharmacology; 2008 Nov; 55(6):1006-14. PubMed ID: 18761360
[TBL] [Abstract][Full Text] [Related]
22. Selective blockade of 5-hydroxytryptamine (5-HT)7 receptors enhances 5-HT transmission, antidepressant-like behavior, and rapid eye movement sleep suppression induced by citalopram in rodents.
Bonaventure P; Kelly L; Aluisio L; Shelton J; Lord B; Galici R; Miller K; Atack J; Lovenberg TW; Dugovic C
J Pharmacol Exp Ther; 2007 May; 321(2):690-8. PubMed ID: 17314195
[TBL] [Abstract][Full Text] [Related]
23. A role for MAP kinase signaling in behavioral models of depression and antidepressant treatment.
Duman CH; Schlesinger L; Kodama M; Russell DS; Duman RS
Biol Psychiatry; 2007 Mar; 61(5):661-70. PubMed ID: 16945347
[TBL] [Abstract][Full Text] [Related]
24. Antidepressant-like effect of agmatine is not mediated by serotonin.
Krass M; Wegener G; Vasar E; Volke V
Behav Brain Res; 2008 Apr; 188(2):324-8. PubMed ID: 18177953
[TBL] [Abstract][Full Text] [Related]
25. Antidepressant-like effects of nicotinic acetylcholine receptor antagonists, but not agonists, in the mouse forced swim and mouse tail suspension tests.
Andreasen JT; Olsen GM; Wiborg O; Redrobe JP
J Psychopharmacol; 2009 Sep; 23(7):797-804. PubMed ID: 18583432
[TBL] [Abstract][Full Text] [Related]
26. Blockade of intracellular calcium release induces an antidepressant-like effect in the mouse forced swimming test.
Galeotti N; Bartolini A; Ghelardini C
Neuropharmacology; 2006 Mar; 50(3):309-16. PubMed ID: 16249008
[TBL] [Abstract][Full Text] [Related]
27. Antidepressant-like activity of Glycyrrhiza glabra L. in mouse models of immobility tests.
Dhingra D; Sharma A
Prog Neuropsychopharmacol Biol Psychiatry; 2006 May; 30(3):449-54. PubMed ID: 16443316
[TBL] [Abstract][Full Text] [Related]
28. Reversal by quercetin of corticotrophin releasing factor induced anxiety- and depression-like effect in mice.
Bhutada P; Mundhada Y; Bansod K; Ubgade A; Quazi M; Umathe S; Mundhada D
Prog Neuropsychopharmacol Biol Psychiatry; 2010 Aug; 34(6):955-60. PubMed ID: 20447436
[TBL] [Abstract][Full Text] [Related]
29. The antidepressant effects of curcumin in the forced swimming test involve 5-HT1 and 5-HT2 receptors.
Wang R; Xu Y; Wu HL; Li YB; Li YH; Guo JB; Li XJ
Eur J Pharmacol; 2008 Jan; 578(1):43-50. PubMed ID: 17942093
[TBL] [Abstract][Full Text] [Related]
30. Antidepressant- and anxiolytic-like activity of magnesium in mice.
Poleszak E; Szewczyk B; Kedzierska E; Wlaź P; Pilc A; Nowak G
Pharmacol Biochem Behav; 2004 May; 78(1):7-12. PubMed ID: 15159129
[TBL] [Abstract][Full Text] [Related]
31. Berberine produces antidepressant-like effects in the forced swim test and in the tail suspension test in mice.
Peng WH; Lo KL; Lee YH; Hung TH; Lin YC
Life Sci; 2007 Aug; 81(11):933-8. PubMed ID: 17804020
[TBL] [Abstract][Full Text] [Related]
32. Antidepressant-like and anxiolytic-like effects of YL-IPA08, a potent ligand for the translocator protein (18 kDa).
Zhang LM; Zhao N; Guo WZ; Jin ZL; Qiu ZK; Chen HX; Xue R; Zhang YZ; Yang RF; Li YF
Neuropharmacology; 2014 Jun; 81():116-25. PubMed ID: 24067925
[TBL] [Abstract][Full Text] [Related]
33. Anxiolytic-like effect of group III mGlu receptor antagonist is serotonin-dependent.
Stachowicz K; Chojnacka-Wójcik E; Kłak K; Pilc A
Neuropharmacology; 2007 Feb; 52(2):306-12. PubMed ID: 17020774
[TBL] [Abstract][Full Text] [Related]
34. Behavioral characterization of the mGlu group II/III receptor antagonist, LY-341495, in animal models of anxiety and depression.
Bespalov AY; van Gaalen MM; Sukhotina IA; Wicke K; Mezler M; Schoemaker H; Gross G
Eur J Pharmacol; 2008 Sep; 592(1-3):96-102. PubMed ID: 18634781
[TBL] [Abstract][Full Text] [Related]
35. Anxiolytic- and antidepressant-like effects of an antagonist at glycineB receptors.
Przegaliński E; Tatarczyńska E; Chojnacka-Wójcik E
Pol J Pharmacol; 1998; 50(4-5):349-54. PubMed ID: 10091720
[TBL] [Abstract][Full Text] [Related]
36. Corticotropin-releasing hormone receptors mediate consensus interferon-alpha YM643-induced depression-like behavior in mice.
Yamano M; Yuki H; Yasuda S; Miyata K
J Pharmacol Exp Ther; 2000 Jan; 292(1):181-7. PubMed ID: 10604946
[TBL] [Abstract][Full Text] [Related]
37. The tail suspension test as a model for assessing antidepressant activity: review of pharmacological and genetic studies in mice.
Cryan JF; Mombereau C; Vassout A
Neurosci Biobehav Rev; 2005; 29(4-5):571-625. PubMed ID: 15890404
[TBL] [Abstract][Full Text] [Related]
38. S32504, a novel naphtoxazine agonist at dopamine D3/D2 receptors: III. Actions in models of potential antidepressive and anxiolytic activity in comparison with ropinirole.
Millan MJ; Brocco M; Papp M; Serres F; La Rochelle CD; Sharp T; Peglion JL; Dekeyne A
J Pharmacol Exp Ther; 2004 Jun; 309(3):936-50. PubMed ID: 14978196
[TBL] [Abstract][Full Text] [Related]
39. Evaluation of the anxiolytic-like profile of the GABAB receptor positive modulator CGP7930 in rodents.
Jacobson LH; Cryan JF
Neuropharmacology; 2008 Apr; 54(5):854-62. PubMed ID: 18328507
[TBL] [Abstract][Full Text] [Related]
40. Depressive-like behavior induced by tumor necrosis factor-α in mice.
Kaster MP; Gadotti VM; Calixto JB; Santos AR; Rodrigues AL
Neuropharmacology; 2012 Jan; 62(1):419-26. PubMed ID: 21867719
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
